STAT+: Novo Nordisk is warned by the FDA for failing to report potential side effects tied to GLP-1 drugs
STAT [Unofficial]
March 10, 2026
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.
Discussion in the ATmosphere